Breast Cancer Clinical Trials in Los Angeles

Showing 101-120 of 453 trials

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

NCT07076147

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.

Breast Carcinoma

University of Southern California150 participantsStarted Jun 2025

Los Angeles, California, United States • Los Angeles, California, United States

RECRUITINGPhase 2< 1 mile

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

NCT06369285

PUMA-ALI-1201 is a randomized, dose optimization, multicenter, Phase 2 study of alisertib administered in combination with endocrine therapy in participants with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two prior lines of endocrine therapy in the recurrent or metastatic setting. This study is intended to evaluate the optimal alisertib dose administered in combination with the selected endocrine therapy. The study is also planned to evaluate the efficacy, safety, and pharmacokinetics of alisertib in combination with endocrine and to identify the biomarker-defined subgroup(s) that may benefit most from combined alisertib and endocrine therapy.

Hormone Receptor Positive HER-2 Negative Breast CancerMetastatic Breast CancerRecurrent Breast Cancer

Puma Biotechnology, Inc.150 participantsStarted Nov 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Beverly Hills, California, United States +50 more locations

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Breast Cancer Survivorship Biorepository

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

A Study of XMT-1660 in Participants With Solid Tumors

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer

A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Study of AVZO-021 in Patients With Advanced Solid Tumors

MARGetuximab Or Trastuzumab (MARGOT)

A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)

Other Conditions in Los Angeles